Additionally, FBXO5 is found to be upregulated in colon cancer and functions by inhibiting ER stress-induced apoptosis through promoting the ubiquitination degradation of RNF183, thereby contributing to colon cancer progression. Here, FBXO5 is linked to malignant colon neoplasm.